Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration.
about
Role of the Retromer Complex in Neurodegenerative DiseasesImmunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein AggregationElevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cellsATP13A2 and Alpha-synuclein: a Metal Taste in AutophagySigma-1 receptor: a potential new target for Parkinson's disease?The Interplay between Alpha-Synuclein Clearance and SpreadingThe mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.Fasudil attenuates aggregation of α-synuclein in models of Parkinson's diseaseToll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology.Posttranslational Modifications and Clearing of α-Synuclein Aggregates in YeastNovel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease.Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.Progress toward an integrated understanding of Parkinson's disease.The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation.Proteasome impairment by α-synuclein.Subcellular Parkinson's Disease-Specific Alpha-Synuclein Species Show Altered Behavior in Neurodegeneration.Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside.
P2860
Q26766012-D66D9F1A-F896-41D4-89A4-E646FC4CC30FQ26781130-F9AA4711-09F1-4892-A31F-3ACB0840C3A6Q27329722-456CFE19-D56C-4842-801F-EB0C115B3EE2Q28116203-1C536C7E-CE47-4B5A-86E4-E5C5EA92487FQ35537759-45ADC732-6280-46E4-9F42-FFE92BDC9536Q35833984-D43BCD71-213D-4E3C-93FA-EC14852223A6Q36296532-FB0816E4-5D3F-4565-9252-C3D1D855A484Q36825541-B91D232C-49FB-4A8F-9AC7-B49C70777902Q37596779-1C98F3E4-7843-439B-9322-076861711985Q38444052-8A73D2DA-3B59-4291-9BA1-BCEEC373692BQ38848617-72DB0DB7-873F-4EA7-9908-5BD60633F9F5Q38972171-672498F0-DC10-4B00-8C1D-992A33260CD7Q40114382-5FFDDCB7-C01D-4BB0-B405-F8E6D83297C9Q41012014-7F14376D-F917-4399-AB9B-B849C8A99EADQ42355152-D4E901C2-D631-49F6-B32B-753944EC8A78Q42363521-392902E8-E373-4E39-B2A1-94E2AB065AF0Q46460788-3412227B-6DD6-4531-A640-448FF4740D5AQ50217393-6E76AA94-2916-4D4F-9DA8-F06CEA0F4BDD
P2860
Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Limelight on alpha-synuclein: ...... ications in neurodegeneration.
@en
type
label
Limelight on alpha-synuclein: ...... ications in neurodegeneration.
@en
prefLabel
Limelight on alpha-synuclein: ...... ications in neurodegeneration.
@en
P2093
P356
P1476
Limelight on alpha-synuclein: ...... lications in neurodegeneration
@en
P2093
Diana F Lázaro
Pauline Wales
Raquel Pinho
P304
P356
10.3233/JPD-130216
P577
2013-01-01T00:00:00Z